You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced RCC

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC (NSCLC), Triple Negative Breast Cancer (TNBC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Worldwide (NZV930, PDR001,

Terminated
  • Non-small Cell Lung Cancer (NSCLC)
  • +6 more
  • NZV930
  • +2 more
  • Tampa, Florida
  • +9 more
Nov 2, 2022

Metastatic Renal Cell Carcinoma Trial in Wien, Essen (Nivolumab, Sunitinib, Pazopanib)

Terminated
  • Metastatic Renal Cell Carcinoma
  • Wien, Austria
  • +1 more
Sep 7, 2021

Locally Advanced or Metastatic Renal Cell Carcinoma Trial in Worldwide (Cabozantinib)

Active, not recruiting
  • Locally Advanced or Metastatic Renal Cell Carcinoma
  • Salzburg, Austria
  • +39 more
Jan 18, 2023

Metastatic Renal Cell Carcinoma Trial in Italy (sorafenib)

Active, not recruiting
  • Metastatic Renal Cell Carcinoma
  • Milan, Mi, Italy
  • +13 more
Sep 16, 2021

Renal Cell Carcinoma (RCC), Urothelial Carcinoma, Primary Peritoneal Cancer Trial in Canada, United States (DSP-7888 Dosing

Completed
  • Renal Cell Carcinoma (RCC)
  • +5 more
  • DSP-7888 Dosing Emulsion
  • +2 more
  • Tucson, Arizona
  • +18 more
Dec 6, 2022

Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

Active, not recruiting
Has Results
  • Metastatic Cancer
  • +9 more
  • Mobile, Alabama
  • +19 more
Aug 1, 2022

Melanoma, Renal Cell Carcinoma, NSCLC Trial in United States (HBI-8000 in combination with nivolumab)

Active, not recruiting
  • Melanoma
  • +2 more
  • HBI-8000 in combination with nivolumab
  • Phoenix, Arizona
  • +5 more
Jun 11, 2022

Advanced Solid Tumors Trial in Australia, China (Sitravatinib)

Completed
  • Advanced Solid Tumors
  • Blacktown, New South Wales, Australia
  • +16 more
Jan 10, 2023

Cervical Cancer, Gastric Cancer, Stomach Cancer Trial in United States (INCAGN02390)

Completed
  • Cervical Cancer
  • +20 more
  • Los Angeles, California
  • +3 more
Nov 12, 2021

Utilization of Cabozantinib in Adult Advanced or Metastatic

Withdrawn
  • Renal Cell Carcinoma
    • (no location specified)
    Dec 17, 2020

    Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)

    Terminated
    Has Results
    • Solid Tumor
    • +6 more
    • Birmingham, Alabama
    • +8 more
    Feb 16, 2022

    Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1 Trial in

    Recruiting
    • Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1
    • Biological : Toripalimab Drug: Axitinib
    • sunitinib
    • Beijing, China
      Beijing Cancer Hospital
    Jan 24, 2021

    Cabozantinib in Advanced Renal Cell Carcinoma (RCC) in UK

    Completed
    • Advanced Renal Cell Carcinoma
      • Brighton, United Kingdom
      • +5 more
      Nov 4, 2020

      ccRCC, RCC, Kidney Cancer Trial in United States (MK-3795, Nivolumab, Cabozantinib)

      Active, not recruiting
      • ccRCC
      • +4 more
      • Los Angeles, California
      • +24 more
      Jul 18, 2022

      Metastatic Renal Cell Carcinoma Trial in Worldwide (Ipilimumab plus nivolumab, Standard Therapy)

      Recruiting
      • Metastatic Renal Cell Carcinoma
      • Ipilimumab plus nivolumab
      • Standard Therapy
      • Gent, Belgium
      • +40 more
      Feb 7, 2022

      Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

      Completed
      • Colorectal Cancer (CRC)
      • +10 more
      • San Francisco, California
      • +16 more
      Mar 30, 2022

      Carcinoma, Renal Cell, NSCLC Trial in Belgium, France (Live Bacterial Product - Akkermansia muciniphila)

      Recruiting
      • Carcinoma, Renal Cell
      • Carcinoma, Non-Small-Cell Lung
      • Live Bacterial Product - Akkermansia muciniphila
      • Mons, Belgium
      • +3 more
      May 9, 2023

      Renal Cell Carcinoma Trial (drug, device, biological, procedure)

      Withdrawn
      • Renal Cell Carcinoma
      • (no location specified)
      Aug 12, 2020

      Clear Cell Renal Cell Carcinoma Trial in United States (Placebo, CB-839, everolimus)

      Completed
      • Clear Cell Renal Cell Carcinoma
      • Placebo
      • +2 more
      • Tucson, Arizona
      • +37 more
      Aug 16, 2021

      Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)

      Active, not recruiting
      • Renal Cell Carcinoma
      • Metastatic Renal Cell Carcinoma
      • bempegaldesleukin
      • +3 more
      • Anchorage, Alaska
      • +108 more
      Mar 31, 2022

      Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma Trial (BGB-A445, Tislelizumab)

      Not yet recruiting
      • Urothelial Carcinoma
      • +2 more
      • (no location specified)
      Dec 15, 2022

      Renal Cell Carcinoma Trial in Worldwide (Atezolizumab, Bevacizumab, RO6874281)

      Completed
      • Renal Cell Carcinoma
      • New Haven, Connecticut
      • +22 more
      Sep 10, 2021

      Spanish Real-World Evidence Cabozantinib

      Recruiting
      • Renal Cell Carcinoma
      • Córdoba, Andalucía, Spain
      • +31 more
      Sep 21, 2021

      Renal Cell Carcinoma, Neoadjuvant Trial (Axitinib plus Toripalimab, radical nephrectomy)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Neoadjuvant
      • Axitinib plus Toripalimab
      • radical nephrectomy
      • (no location specified)
      Feb 12, 2023

      Renal Cell Carcinoma Trial in Rome (donor FMT, Placebo FMT)

      Recruiting
      • Renal Cell Carcinoma
      • donor FMT
      • Placebo FMT
      • Rome, Italy
      • +1 more
      Jul 26, 2022